Adverse obstetric outcomes in pregnant women with uterine fibroids in China: A multicenter survey involving 112,403 deliveries
- PMID: 29136018
- PMCID: PMC5685483
- DOI: 10.1371/journal.pone.0187821
Adverse obstetric outcomes in pregnant women with uterine fibroids in China: A multicenter survey involving 112,403 deliveries
Abstract
Objective: To estimate the association between uterine fibroids and adverse obstetric outcomes.
Methods: This was a retrospective cross-sectional study of 112,403 deliveries from 14 provinces and 39 different hospitals in 2011 in mainland China. We compared pregnancy outcomes in women with and without uterine fibroids who underwent detailed second trimester obstetric ultrasonography during 18 to 22 weeks. Obstetric outcomes include cesarean delivery, breech presentation, preterm delivery, placenta previa, placental abruption, premature rupture of membranes and neonatal birthweight. Univariate analyses and multivariate logistic regression analyses were performed.
Results: Of 112,403 women who underwent routine obstetric survey, 3,012 (2.68%) women were identified with at least 1 fibroid. By univariate and multivariate analyses, the presence of uterine fibroids was significantly associated with cesarean delivery (Adjusted odds radio [AOR] 1.8, 95% confidence interval [CI] 1.7-2.0), breech presentation (AOR 1.3, 95% CI 1.2-1.5) and postpartum hemorrhage (AOR 1.2, 95% CI 1.1-1.4). The size of uterine fibroids and location in uterus had important effect on the mode of delivery. The rates of PPH were significantly higher with increasing size of the uterine fibroid (P<0.001). And the location of fibroid (intramural, submucosal or subserosal) also have a statistically significant impact on the risk of PPH (5.6% [subserosal] vs 4.7% [submucosal] vs 8.6% [intramural]).
Conclusion: Pregnant women with uterine fibroids are at increased risk for cesarean delivery, breech presentation and postpartum hemorrhage. And different characteristics of uterine fibroids affect obstetric outcomes through different ways. Such detailed information may be useful in risk-stratifying pregnant women with fibroids.
Conflict of interest statement
Figures
References
-
- Levy BS: Modern management of uterine fibroids. Acta obstetricia et gynecologica Scandinavica 2008, 87(8):812–823. doi: 10.1080/00016340802146912 - DOI - PubMed
-
- Coronado GD, Marshall LM, Schwartz SM: Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstetrics and gynecology 2000, 95(5):764–769. - PubMed
-
- Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE: Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstetrics and gynecology 2009, 113(3):630–635. doi: 10.1097/AOG.0b013e318197bbaf - DOI - PMC - PubMed
-
- Drayer SM, Catherino WH: Prevalence, morbidity, and current medical management of uterine leiomyomas. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2015, 131(2):117–122. - PubMed
-
- Donnez J, Hudecek R, Donnez O, Matule D, Arhendt HJ, Zatik J, et al. : Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertility and sterility 2015, 103(2):519–527.e513. doi: 10.1016/j.fertnstert.2014.10.038 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
